Document ID: chunk:federal_register_of_legislation:F2024C01228:reg:106
Version: federal_register_of_legislation:F2024C01228
Segment Type: reg
Provision Reference: reg 106
Character Range: 48136–49585

106   Vaccine                                                                                                                                                                                                                                                                                Meningitec         Injection (0.5mL)                                                                 Meningococcal group C oligosaccharide conjugated to diphtheria protein — 10 µg                                                                                                                                                                                                                                                                                 1 dose
      Meningococcal C (conjugate)

      Circumstances
      Vaccine may be provided:
       (a) to a child who is about 12 months old; or
       (b) in the period commencing on 1 January 2006 and ending at the end of 30 June 2007, to a person:
       (i) who, on 1 January 2003, was at least 1 year but less than 20 years of age; and
       (ii) who has not received a vaccine mentioned in this item or item 106 or 107; or
       (c) a person who is undergoing treatment, or will commence treatment, with Empavali (pegcetacoplan) for the treatment of adults with paroxysmal nocturnal haemoglobinuria who have an inadequate clinical response or are intolerant to treatment with eculizumab or ravulizumab.